Rx Medicare

Two common anti-influenza drugs – Relenza and Tamiflu – appear equally effective at preventing common flu symptoms when given before infection, say researchers from the Stanford University School of Medicine. However, data is lacking on the effectiveness and safety of the two drugs in vulnerable groups such as the very young and people with compromised immune systems.

Read More…

Related Posts

• Vaccinating Children For Flu May Help Prevent Transmission, Protect Those Who Are Not Vaccinated
• Pandemic Flu, Like Seasonal H1N1, Shows Signs Of Resisting Tamiflu
• Toward A Less Expensive Version Of The Anti-flu Drug Tamiflu
• Drive-Through Emergency Service Effective Response To Pandemic, Stanford Study Shows
• Research Suggests That Mutagenic Drugs Designed To Kill Viruses May Make Them Stronger
• Update On Person To Person Spread Of Swine Flu Resistant To Tamiflu, Wales
• China, WHO To Collaborate On Flu Research Center
• New Model May Help Scientists Better Predict And Prevent Influenza Outbreaks
• Lucile Packard Children’s Hospital And Stanford Hospital & Clinics Implement New Visiting Policy To Limit Presence, Spread Of H1N1 Flu To Patients
• U.S. Department Of Health And Human Services And The Ad Council Launch National Campaign To Help Prevent The Spread Of The H1N1 Flu Virus
• Amarillo Biosciences Reports On Research Supporting Use Of Interferon To Combat Influenza
• Publix Pharmacies To Compound Tamiflu Into Oral Suspension
• Tamiflu Metabolite Measured In Japanese Sewage Discharge, River Water
• New Target To Prevent Fatal Flu Lung Complication identified by LSUHSC Researcher
• Walgreens To Compound Tamiflu Oral Suspension For Children In Response To Supply Shortage

Tags: assesses, efficacy, prevent, relenza, research, stanford, tamiflu

This entry was posted on Friday, August 7th, 2009 at 12:08 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.